The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
MC1R Genotype Modifies Risk of Melanoma in Families Segregating CDKN2A Mutations
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751 · cited 2×
“…different genes have been shown to influence risk of melanoma: cyclin-dependent kinase inhibitor 2A (CDKN2A [MIM 600160]) (Hussussian et al. 1994; Kamb et al. 1994a), cyclindependent kinase 4 (CDK4 [MIM 123829]) (Zuo et al. 1996; Soufir et al. 1998), and the melanocortin-1 receptor (MC1R [MIM…”
BackgroundDeletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Valverde, P., Healy, E., Jackson, I., Rees, J. L., & Thody, A. J. (1995) · Nature Genetics · doi:10.1038/ng1195-328 · Cited by 999
Germline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
The p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911
The TDT and other family-based tests for linkage disequilibrium and association.
(1996) · PubMed Central · Cited by 901
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855
Self-citationGermline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C. (1996) · Nature Genetics · doi:10.1038/ng0196-97 · Cited by 818 · cited 2×
“…shown to influence risk of melanoma: cyclin-dependent kinase inhibitor 2A (CDKN2A [MIM 600160]) (Hussussian et al. 1994; Kamb et al. 1994a), cyclindependent kinase 4 (CDK4 [MIM 123829]) (Zuo et al. 1996; Soufir et al. 1998), and the melanocortin-1 receptor (MC1R [MIM 155555]) (Palmer et al. 2000).”
BackgroundSelf-citation
Cited by
Malignant melanoma: genetics and therapeutics in the genomic era
Chin, L., Garraway, L. A., & Fisher, D. E. (2006) · Genes & Development · doi:10.1101/gad.1437206 · Cited by 511
Epidemiology of invasive cutaneous melanoma
MacKie, R. M., Hauschild, A., & Eggermont, A. M. M. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp252 · Cited by 405
Human pigmentation genes: identification, structure and consequences of polymorphic variation
Sturm, R. A., Teasdale, R. D., & Box, N. F. (2001) · Gene · doi:10.1016/s0378-1119(01)00694-1 · Cited by 390
Self-citationSturm, R. A., Duffy, D. L., Zhao, Z. Z., Leite, F. P. N., Stark, M. S., Hayward, N. K., Martin, N. G., & Montgomery, G. W. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.11.005 · Cited by 378
Beyond Mendel: an evolving view of human genetic disease transmission
Badano, J. L., & Katsanis, N. (2002) · Nature Reviews Genetics · doi:10.1038/nrg910 · Cited by 366
Genetics of melanoma predisposition
Hayward, N. K. (2003) · Oncogene · doi:10.1038/sj.onc.1206445 · Cited by 321
Self-citationThe genetics of malignant melanoma: lessons from mouse and man
Chin, L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1145 · Cited by 302
The Genetics of Sun Sensitivity in Humans
Rees, J. L. (2004) · The American Journal of Human Genetics · doi:10.1086/425285 · Cited by 289
Melanoma epidemiology, biology and prognosis
Ali, Z., Yousaf, N., & Larkin, J. (2013) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2013.07.012 · Cited by 278
Melanoma etiology: where are we?
Tucker, M. A., & Goldstein, A. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206444 · Cited by 268
Interactive effects of MC1R and OCA2 on melanoma risk phenotypes
Duffy, D. L. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh043 · Cited by 257
Self-citationMC 1R, the c AMP pathway, and the response to solar UV: extending the horizon beyond pigmentation
García‐Borrón, J. C., Abdel‐Malek, Z., & Jiménez‐Cervantes, C. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12257 · Cited by 187
MC1R and the response of melanocytes to ultraviolet radiation
Rouzaud, F., Kadekaro, A. L., Abdel-Malek, Z. A., & Hearing, V. J. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.09.014 · Cited by 173
Abdel-Malek, Z. A., Kadekaro, A. L., & Swope, V. B. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00679.x · Cited by 134
Kadekaro, A. L., Leachman, S., Kavanagh, R. J., Swope, V., Cassidy, P., Supp, D., Sartor, M., Schwemberger, S., Babcock, G., Wakamatsu, K., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-158485 · Cited by 130
Self-citationKadekaro, A. L., Chen, J., Yang, J., Chen, S., Jameson, J., Swope, V. B., Cheng, T., Kadakia, M., & Abdel-Malek, Z. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0436 · Cited by 122
The Melanocortin 1 Receptor and the UV Response of Human Melanocytes—A Shift in Paradigm†
Abdel‐Malek, Z. A., Knittel, J., Kadekaro, A. L., Swope, V. B., & Starner, R. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00294.x · Cited by 111
MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2)
King, R. A., Willaert, R. K., Schmidt, R. M., Pietsch, J., Savage, S., Brott, M. J., Fryer, J. P., Summers, C. G., & Oetting, W. S. (2003) · The American Journal of Human Genetics · doi:10.1086/377569 · Cited by 98
Abdel‐Malek, Z. A., Ruwe, A., Kavanagh‐Starner, R., Kadekaro, A. L., Swope, V., Haskell‐Luevano, C., Koikov, L., & Knittel, J. J. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00598.x · Cited by 83
The Role of Inherited Pathogenic CDKN2A Variants in Susceptibility to Pancreatic Cancer
Kimura, H., Klein, A. P., Hruban, R. H., & Roberts, N. J. (2021) · Pancreas · doi:10.1097/mpa.0000000000001888 · Cited by 65
Swope, V. B., & Abdel-Malek, Z. A. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00146 · Cited by 51
April, C. S., & Barsh, G. S. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030009 · Cited by 42
Leonard, J. H., Marks, L. H., Chen, W., Cook, A. L., Boyle, G. M., Smit, D. J., Brown, D. L., Stow, J. L., Parsons, P. G., & Sturm, R. A. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00033.x · Cited by 39
Familial malignant melanoma ‐ overview
Dębniak, T. (2004) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-2-3-123 · Cited by 17
Metadata
- Authors
- Box, N. F., Duffy, D. L., Chen, W., Stark, M., Martin, N. G., Sturm, R. A., & Hayward, N. K.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2001-10
- Volume
- 69
- Issue
- 4
- Pages
- 765-773
- ISSN
- 0002-9297 (ISSN-L)
- OpenAlex
- W2167028317
- Cited by
- 310
- References
- 42
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.